Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: RED+BLUE STRATEGIES
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: RED+BLUE STRATEGIES
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HIMS&HERS via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to compounding/telehealth/health care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNTAIN HOUSE via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Source: Senate LDA
| DAVITA INC. |
| 2 |
| 2026 |
| FOUNTAIN HOUSE | 2 | 2026 |
| GE HEALTHCARE | 2 | 2026 |
| GENEDX, LLC | 2 | 2026 |
| GREATER NEW YORK HOSPITAL ASSOCIATION | 2 | 2026 |
| HIMS&HERS | 2 | 2026 |
| HPA MANAGEMENT GROUP INC. | 2 | 2026 |
| KAROO HEALTH | 2 | 2026 |
| MOUNT SINAI HOSPITALS GROUP, INC | 2 | 2026 |
| PRIME THERAPEUTICS | 2 | 2026 |
| QUEST DIAGNOSTICS INCORPORATED | 2 | 2026 |
| THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA | 2 | 2026 |
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Genomic Answers for Children’s Health Act of 2026
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder.
Genomic Answers for Children’s Health Act of 2026
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder
H–1Bs for Physicians and the Healthcare Workforce Act
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States
H–1Bs for Physicians and the Healthcare Workforce Act
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Issues related to organ transplantation
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Tax Exempt Hospital Transparency Act
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Issues related to graduate medical education (GME) slots. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Tax Exempt Hospital Transparency Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Tax Exempt Hospital Transparency Act
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements
Tax Exempt Hospital Transparency Act
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements Monitor issues and proposals related to health care price transparency
Regulatory issues related to Medicaid and CHIP. Monitor issues related to 340B, including H.R.9599 - SECURE 340B Act.
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Future in Logging Careers Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Future in Logging Careers Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Servicemember Credit Monitoring Enhancement Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Servicemember Credit Monitoring Enhancement Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Seedlings for Sustainable Habitat Restoration Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Seedlings for Sustainable Habitat Restoration Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
DOC Access Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
DOC Access Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Issues related to mental health, highlighting the clubhouse model of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to Pharmacy Benefit Managers and Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI HOSPITALS GROUP, INC via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitor issues and proposals related to health care price transparency. Monitor rulemaking related federal grants. Monitor issues related to AI in the health care space.
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAROO HEALTH via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Highlight the potential of innovative approaches for caring for cardiac patients.
Issues related to advancing innovative approaches to care for patients and their providers covered by public and private health insurance programs.
Issues related to advancing innovative approaches to care for patients and their providers covered by the Medicare and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HPA MANAGEMENT GROUP INC. via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to technology to improve Medicaid outreach and enrollment. Issues related to the expansion of TrumpRx. Monitor issues related to maternal health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Issues related to graduate medical education (GME) slots.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitor issues related to 340B.
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, LLC via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to tricare genetic testing.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder.
GE HEALTHCARE via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to research and access to women's health screenings. Issues related to research and coverage of diagnostic procedures utilizing radiopharmaceuticals. Issues related to artificial intelligence and its role in the health care system.
Issues related to Veterans Affairs (VA) acquisition policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHAPTER via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to technology to improve Medicare.gov. Issues related to Medicare brokers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicare Advantage: Star Ratings.
Regulatory issues related to Medicare Advantage and the ACA Marketplace. Issues related to pharmacy benefit managers and their role in insurance coverage. Issues related to surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON MEDICAL CENTER via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicaid and CHIP. Monitor issues related to 340B, including H.R.9599 - SECURE 340B Act.
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicare Advantage and the ACA Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYCARE HEALTH SYSTEM via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Issues related to organ transplantation
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Monitor FY27 Commerce, Justice, Science, and Related Agencies bill.
AMERICAN HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS&HERS via RED+BLUE STRATEGIES
2026 · third_quarter · RR
Issues related to compounding/telehealth/health care.
PRIME THERAPEUTICS via RED+BLUE STRATEGIES
2026 · third_quarter · RR
Issues related to Pharmacy Benefit Managers and Medicare Part D.
QUEST DIAGNOSTICS INCORPORATED via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to Federal Emergency Management Agency (FEMA) reimbursement for COVID-19 work.
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
KAROO HEALTH via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to advancing innovative approaches to care for patients and their providers covered by public and private health insurance programs.
Issues related to advancing innovative approaches to care for patients and their providers covered by the Medicare and Medicaid programs.
Highlight the potential of innovative approaches for caring for cardiac patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, LLC via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GE HEALTHCARE via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to Veterans Affairs (VA) acquisition policy
Issues related to research and access to women's health screenings. Issues related to research and coverage of diagnostic procedures utilizing radiopharmaceuticals. Issues related to artificial intelligence and its role in the health care system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to Medicare Advantage: Star Ratings.
Regulatory issues related to Medicare Advantage and the ACA Marketplace. Issues related to pharmacy benefit managers and their role in insurance coverage. Issues related to surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON MEDICAL CENTER via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Regulatory issues related to Medicaid and CHIP. Monitor issues related to 340B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to Medicare Advantage and the ACA Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHAPTER via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to technology to improve Medicare.gov. Issues related to Medicare brokers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HPA MANAGEMENT GROUP INC. via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to technology to improve Medicaid outreach and enrollment. Issues related to the expansion of TrumpRx.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
MOUNT SINAI HOSPITALS GROUP, INC via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements Monitor issues and proposals related to health care price transparency
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
BAYCARE HEALTH SYSTEM via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Monitor FY27 Commerce, Justice, Science, and Related Agencies bill
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements
FOUNTAIN HOUSE via RED+BLUE STRATEGIES
2026 · third_quarter · RR
Issues related to mental health, highlighting the clubhouse model of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Issues related to graduate medical education (GME) slots. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
Issues related to Federal Emergency Management Agency (FEMA) reimbursement for COVID-19 work.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE